← Back to Search

BIPAS Alcohol Intervention for Preventing Adolescent Alcohol Use

N/A

Recruiting

Led By Nisha Gottfredson, PhD

Research Sponsored by University of North Carolina, Chapel Hill

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, three months

Awards & highlights

Study Summary

This trial is testing an intervention to prevent early alcohol use by educating parents of rising 6th grade students. The intervention capitalizes on the influence of providers, immunization timing, and pediatric guidelines.

Who is the study for?

This trial is for parents or guardians over 18 who live with a child aged 10-12 at least part-time, can consent to participate, speak English, and have a phone with texting and internet. It's not for families where the child is being treated for alcohol use disorder.Check my eligibility

What is being tested?

The BIPAS Alcohol program aims to prevent early alcohol use in adolescents by educating parents during pediatric visits and reinforcing messages through technology. The study will assess how well this approach works with families of rising 6th graders.See study design

What are the potential side effects?

Since this intervention involves education and communication rather than medication, there are no direct medical side effects; however, participants may experience changes in family dynamics or behavior as they discuss alcohol prevention.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, three months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, three months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, three months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Parental Pro-sipping Beliefs Score

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention armExperimental Treatment1 Intervention

Families receive text messages for three months.

Group II: Waitlist-control armActive Control1 Intervention

Families are randomized into a control group for three months and begin receiving text messages for three months.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor

1,508 Previous Clinical Trials

4,190,942 Total Patients Enrolled

4 Trials studying Adolescent Behaviors

653 Patients Enrolled for Adolescent Behaviors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

801 Previous Clinical Trials

1,365,185 Total Patients Enrolled

2 Trials studying Adolescent Behaviors

460 Patients Enrolled for Adolescent Behaviors

Nisha Gottfredson, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Media Library

BIPAS Alcohol Clinical Trial Eligibility Overview. Trial Name: NCT05520333 — N/A

Adolescent Behaviors Research Study Groups: Intervention arm, Waitlist-control arm

Adolescent Behaviors Clinical Trial 2023: BIPAS Alcohol Highlights & Side Effects. Trial Name: NCT05520333 — N/A

BIPAS Alcohol 2023 Treatment Timeline for Medical Study. Trial Name: NCT05520333 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrollees still being accepted for this experiment?

"Clinicaltrials.gov confirms that this medical study, which was initially posted on March 1st 2023 and last edited on August 31st 2022, is not currently searching for new participants. Nevertheless, 309 other trials are actively recruiting candidates."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Brief Intervention to Prevent Alcohol Socialization (BIPAS Alcohol)

2023. "Brief Intervention to Prevent Alcohol Socialization (BIPAS Alcohol)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05520333.